Imagem Esquerda
35º Congresso Mineiro de Cardiologia
Imagem Direita
1º Dia - 8/1/26
2º Dia - 7/30/26
3º Dia - 7/31/26

AAS na prevenção primária Voltar

ARMANDO MARTINS PINTO e LEONOR DE OLIVEIRA DINIZ

CONTROVÉRSIAS 02 - FABIO LOURES PERALVA e JOEL TELES CORREA DE OLIVEIRA

Artigo Autor(es) Referência
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Part 1, Lifestyle and Behavioral Factors. Arnett Donna K, Khera Amit, Blumenthal Roger S JAMA cardiology. 2019 Oct; 4(Oct):1043-1044. doi: 10.1001/jamacardio.2019.2604. pii: .
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Visseren Frank L J, Mach François, Smulders Yvo M, Carballo David, Koskinas Konstantinos C, Bäck Maria, Benetos Athanase, Biffi Alessandro, Boavida José-Manuel, Capodanno Davide, Cosyns Bernard, Crawford Carolyn, Davos Constantinos H, Desormais Ileana, Di Angelantonio Emanuele, Franco Oscar H, Halvorsen Sigrun, Hobbs F D Richard, Hollander Monika, Jankowska Ewa A, Michal Matthias, Sacco Simona, Sattar Naveed, Tokgozoglu Lale, Tonstad Serena, Tsioufis Konstantinos P, van Dis Ineke, van Gelder Isabelle C, Wanner Christoph, Williams Bryan, European journal of preventive cardiology. 2022 Feb; 29(Feb):5-115. doi: 10.1093/eurjpc/zwab154. pii: .
Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement. , Davidson Karina W, Barry Michael J, Mangione Carol M, Cabana Michael, Chelmow David, Coker Tumaini Rucker, Davis Esa M, Donahue Katrina E, Jaén Carlos Roberto, Krist Alex H, Kubik Martha, Li Li, Ogedegbe Gbenga, Pbert Lori, Ruiz John M, Stevermer James, Tseng Chien-Wen, Wong John B JAMA. 2022 Apr; 327(Apr):1577-1584. doi: 10.1001/jama.2022.4983. pii: .
Aspirin for Primary Prevention of Cardiovascular Disease in the 21st Century: A Review of the Evidence. Angiolillo Dominick J, Capodanno Davide The American journal of cardiology. 2021 Apr; 144 Suppl 1(Apr):S15-S22. doi: 10.1016/j.amjcard.2020.12.022. pii: S0002-9149(20)31349-7.
Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups. Gelbenegger Georg, Postula Marek, Pecen Ladislav, Halvorsen Sigrun, Lesiak Maciej, Schoergenhofer Christian, Jilma Bernd, Hengstenberg Christian, Siller-Matula Jolanta M BMC medicine. 2019 Nov; 17(Nov):198. doi: 10.1186/s12916-019-1428-0. pii: 198.
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. , Baigent Colin, Blackwell Lisa, Collins Rory, Emberson Jonathan, Godwin Jon, Peto Richard, Buring Julie, Hennekens Charles, Kearney Patricia, Meade Tom, Patrono Carlo, Roncaglioni Maria Carla, Zanchetti Alberto Lancet (London, England). 2009 May; 373(May):1849-60. doi: 10.1016/S0140-6736(09)60503-1. pii: .
Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis. Zheng Sean L, Roddick Alistair J JAMA. 2019 Jan; 321(Jan):277-287. doi: 10.1001/jama.2018.20578. pii: .
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly. McNeil John J, Nelson Mark R, Woods Robyn L, Lockery Jessica E, Wolfe Rory, Reid Christopher M, Kirpach Brenda, Shah Raj C, Ives Diane G, Storey Elsdon, Ryan Joanne, Tonkin Andrew M, Newman Anne B, Williamson Jeff D, Margolis Karen L, Ernst Michael E, Abhayaratna Walter P, Stocks Nigel, Fitzgerald Sharyn M, Orchard Suzanne G, Trevaks Ruth E, Beilin Lawrence J, Donnan Geoffrey A, Gibbs Peter, Johnston Colin I, Radziszewska Barbara, Grimm Richard, Murray Anne M, The New England journal of medicine. 2018 10; 379(10):1519-1528. doi: 10.1056/NEJMoa1803955. pii: .
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly. McNeil John J, Wolfe Rory, Woods Robyn L, Tonkin Andrew M, Donnan Geoffrey A, Nelson Mark R, Reid Christopher M, Lockery Jessica E, Kirpach Brenda, Storey Elsdon, Shah Raj C, Williamson Jeff D, Margolis Karen L, Ernst Michael E, Abhayaratna Walter P, Stocks Nigel, Fitzgerald Sharyn M, Orchard Suzanne G, Trevaks Ruth E, Beilin Lawrence J, Johnston Colin I, Ryan Joanne, Radziszewska Barbara, Jelinek Michael, Malik Mobin, Eaton Charles B, Brauer Donna, Cloud Geoff, Wood Erica M, Mahady Suzanne E, Satterfield Suzanne, Grimm Richard, Murray Anne M, The New England journal of medicine. 2018 10; 379(10):1509-1518. doi: 10.1056/NEJMoa1805819. pii: .
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus. , Bowman Louise, Mafham Marion, Wallendszus Karl, Stevens Will, Buck Georgina, Barton Jill, Murphy Kevin, Aung Theingi, Haynes Richard, Cox Jolyon, Murawska Aleksandra, Young Allen, Lay Michael, Chen Fang, Sammons Emily, Waters Emma, Adler Amanda, Bodansky Jonathan, Farmer Andrew, McPherson Roger, Neil Andrew, Simpson David, Peto Richard, Baigent Colin, Collins Rory, Parish Sarah, Armitage Jane The New England journal of medicine. 2018 Oct; 379(Oct):1529-1539. doi: 10.1056/NEJMoa1804988. pii: .
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial. Gaziano J Michael, Brotons Carlos, Coppolecchia Rosa, Cricelli Claudio, Darius Harald, Gorelick Philip B, Howard George, Pearson Thomas A, Rothwell Peter M, Ruilope Luis Miguel, Tendera Michal, Tognoni Gianni, Lancet (London, England). 2018 09; 392(09):1036-1046. doi: 10.1016/S0140-6736(18)31924-X. pii: S0140-6736(18)31924-X.
Nenhuma revista foi definida para este congresso.